Keywords: Boehringer Ingelheim, Runxional Thera, FX125, Somatotaxin, Asthama, COPD, Rheumatoid arthritis
Boehringer Ingelheim acquires Funxional products
Article | 24 July 2012
German family-controlled drug major Boehringer Ingelheim has entered an agreement to acquire the global rights to privately-held UK company Funxional ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Negative US patent ruling for Novo Nordisk on Prandin
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Daiichi Sankyo files for Japanese approval of Prasugrel
